Source: Arranta Bio Blog

Arranta Bio Blog Join Us! Microbiome Connect ASIA | May 17-18, 2023 | Seoul, Korea

We are excited to be exhibiting at Microbiome Connect Asia, taking place May 17-18, 2023 in Seoul, Korea. Arranta and Vibalogics offer CDMO capabilities from preclinical to clinical and commercial approval for new biological modalities. Encompassing technologies based on live viruses and viral vectors, live-microbial biopharmaceutical products, nucleic acid-based mRNA and plasmid DNA production. Come [...]The post Join Us! Microbiome Connect ASIA | May 17-18, 2023 | Seoul, Korea appeared first on ArrantaBio.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Mark Bamforth's photo - Founder & CEO of Arranta Bio

Founder & CEO

Mark Bamforth

CEO Approval Rating

84/100

Read more